logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
G

Guillermo Montalban-Bravo

the university of texas m d anderson cancer center
H指数:43
被引数:7,355

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An all-oral triplet regimen (decitabine/cedazuridine, venetoclax, and gilteritinib) for newly diagnosed and relapsed/refractory FLT3-mutated AML and high-risk MDS

口服三联方案（地西他滨/西达苯胺、维奈克拉和吉列替尼）用于新诊断和复发/难治性FLT3突变急性髓系白血病及高风险骨髓增生异常综合征

Blood Cancer Journal
IF11.6
2026-10-130
OAAI
Roberta S. Azevedo; Nicholas J. Short; Alex Bataller; Naval Daver; Tapan M. Kadia; Courtney DiNardo; Alexandre Bazinet; Ghayas Issa; Elias Jabbour; Gautam Borthakur; Jayastu Senapati; Wei-Ying Jen; Kelly Chien; Steven Kornblau; Dono Tippett; Musa Yilmaz; Guillermo Montalban-Bravo; Xuelin Huang; Wei Qiao; Hagop Kantarjian; Guillermo Garcia-Manero; Farhad Ravandi
Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia

新诊断急性髓系白血病中NPM1突变相关的临床结局

Cancer
IF5.1
2026-08-130
OAAI
Aziz Farhat MD; Georgina El Hajjar MD; Hagop Kantarjian MD; Koji Sasaki MD, PhD; Nicholas J. Short MD; Branko Cuglievan MD; Sanam Loghavi MD; Keyur Patel MD, PhD; Alex Bataller MD, PhD; Wei Ying Jen MA, BMBCh, MRCP, MMed, FRCPath; Musa Yilmaz MD; Guillermo Montalban-Bravo MD; Danielle Hammond MD; Naveen Pemmaraju MD; Naval Daver MD; Farhad Ravandi MD; Elias Jabbour MD; Tapan Kadia MD; Gautam Borthakur MD; Guillermo Garcia-Manero MD; Courtney D. DiNardo MD; Ghayas C. Issa MD, MS
Predictors of Relapse and Post-Relapse Outcomes After Frontline Blinatumomab in Philadelphia Chromosome-Negative B-ALL

Ph1阴性B-ALL一线治疗使用blinatumomab后复发的预测因素及复发后结局

American Journal of Hematology
IF9.9
2026-05-170
OAAI
Sankalp Arora; Hagop Kantarjian; Koji Sasaki; Nitin Jain; Zhouxuan Li; Wei Qiao; Sanam Loghavi; Guilin Tang; Caitlin Rausch; Farhad Ravandi; Fadi G. Haddad; Jayastu Senapati; Guillermo Montalban Bravo; Alexandre Bazinet; Rita Khouri; Rebecca Garris; Guillermo Garcia-Manero; Nicholas J. Short; Elias Jabbour
Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromes

异基因造血干细胞移植对高风险骨髓增生异常综合征患者的影响

Blood Cancer Journal
IF11.6
2026-03-270
OAAI
Alexandre Bazinet; Alex Bataller; Kelly Chien; Koji Sasaki; Guillermo Montalban-Bravo; Danielle Hammond; Ian Bouligny; Mahesh Swaminathan; Wei Ying Jen; Eitan Kugler; Rashmi Kanagal-Shamanna; Tapan Kadia; Gautam Borthakur; Courtney DiNardo; Nicholas Short; Naveen Pemmaraju; Elias Jabbour; Naval Daver; Farhad Ravandi; Samuel Urrutia; Georgina Gener-Ricos; Julie Braish; Robert Briski; Juan Jose Rodriguez-Sevilla; Ziyi Li; Richard E. Champlin; Elizabeth J. Shpall; Amin Alousi; Betul Oran; Chitra Hosing; Jeremy L. Ramdial; Amanda Olson; Sherry Pierce; Julianne Chen; Hagop Kantarjian; Guillermo Garcia-Manero; Uday Popat
Correction: Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia

更正：维奈克拉联合FLAG-IDA诱导和巩固治疗新诊断及复发或难治性急性髓系白血病的长期结果

Leukemia
IF13.4
2025-12-100
OAAI
Courtney D. DiNardo; Wei-Ying Jen; Koichi Takahashi; Tapan M. Kadia; Sanam Loghavi; Naval G. Daver; Lianchun Xiao; Patrick K. Reville; Ghayas C. Issa; Nicholas J. Short; Koji Sasaki; Sa A. Wang; Jillian K. Mullin; Sherry Pierce; Corey Bradley; Gautam Borthakur; Abhishek Maiti; Yesid Alvarado; Naveen Pemmaraju; Alessandra Ferrajoli; Mahesh Swaminathan; Maro Ohanian; Hussein A. Abbas; Danielle Hammond; Jan Burger; Fadi Haddad; Guillermo Montalban-Bravo; Kelly Chien; Lucia Masarova; Musa Yilmaz; Nitin Jain; Michael Andreeff; Guillermo Garcia-Manero; Steven Kornblau; Farhad Ravandi; Elias Jabbour; Marina Y. Konopleva; Hagop M. Kantarjian
Outcomes of Patients with IDH1-Mutated Myeloid Neoplasms Treated with Olutasidenib

IDH1突变髓系肿瘤患者接受Olutasidenib治疗后的临床结局

Clinical Lymphoma Myeloma and Leukemia
IF2.7
2025-12-100
PRE
Kelly S. Chien; Sanam Loghavi; Koji Sasaki; Deborah McCue; Naval G. Daver; Tapan M. Kadia; Farhad Ravandi; Nicholas J. Short; Ghayas C. Issa; Guillermo Montalban-Bravo; Fadi G. Haddad; Danielle E. Hammond; Mahesh Swaminathan; Alexandre Bazinet; Alex Bataller; Ian Bouligny; Sherry A. Pierce; Guillermo Garcia-Manero; Hagop M. Kantarjian; Courtney D. DiNardo
Chronic myelomonocytic leukemia in the young (aged 50 years and younger): Divergent clinical and molecular characteristics from the elderly

青年型慢性髓单核细胞白血病（50岁及以下）：与老年患者的临床及分子特征差异

CANCER
IF5.1
2025-11-150
OA
Ok, Chi Young; Natu, Anuya; Daneshpajouhnejad, Parnaz; Fathalla, Lamiaa A.; Symes, Emily; Barone, Paul; Shestakova, Anna; Foucar, Kathryn K.; Bueso-Ramos, Carlos; Montalban-Bravo, Guillermo; Orazi, Attilio; Patnaik, Mrinal; Hasserjian, Robert; Arber, Daniel; Geyer, Julia T.; Bagg, Adam; Reichard, Kaaren K.; Wang, Sa A.
Decitabine-cedazuridine in patients with MDS and TP53 mutations

地西他滨-西达佐鲁定在伴TP53突变的患者中的研究

Blood Advances
IF7.1
2025-11-140
OAAI
Samuel Urrutia; Koji Sasaki; Alex Bataller; Hagop Kantarjian; Guillermo Montalban-Bravo; James McCloskey; Elizabeth A. Griffiths; Karen Yee; Amer Zeidan; Michael Savona; Aram Oganesian; Yuri Sano; Harold N. Keer; Guillermo García-Manero
Cladribine, high-dose cytarabine, plus gemtuzumab ozogamicin (CLAG-GO) as frontline intensive therapy for fit patients with core-binding factor acute myeloid leukemia

Cladribine、高剂量cytarabine，以及gemtuzumab ozogamicin（CLAG-GO）作为core-binding factor急性髓系白血病适合患者的初始强化治疗。

LEUKEMIA & LYMPHOMA
IF2.2
2025-10-010
PRE
Azevedo, Roberta S.; Braish, Julie; Gener-Ricos, Georgina; Tang, Guilin; Sasaki, Koji; Montalban-Bravo, Guillermo; Jabbour, Elias; Ohanian, Maro; Yilmaz, Musa; Haddad, Fadi G.; Chien, Kelly; Ishizawa, Jo; Short, Nicholas J.; Maiti, Abhishek; Swaminathan, Mahesh; Kantarjian, Hagop; Borthakur, Gautam; Kadia, Tapan M.
MECOM fusion partner and bone marrow blast percentage influence outcomes of patients with MECOM rearranged acute myeloid leukaemia

MECOM融合伙伴和骨髓原始细胞百分比影响MECOM重排急性髓系白血病患者预后

British Journal of Haematology
IF3.8
2025-09-220
PRE
Wei-Ying Jen; Guilin Tang; Eitan Kugler; Jennifer Croden; Koji Sasaki; Alexandre Bazinet; Alex Bataller; Guillermo Montalban-Bravo; Gautam Borthakur; Gokce A. Toruner; Sanam Loghavi; Nicholas J. Short; Ghayas C. Issa; Ian M. Bouligny; Sherry Pierce; Uday Popat; Naveen Pemmaraju; Elias Jabbour; Guillermo Garcia-Manero; Kapil Bhalla; Farhad Ravandi; Naval G. Daver; Courtney D. DiNardo; Hagop M. Kantarjian; Tapan M. Kadia
Impact of discordant revised versus molecular international prognostic scoring system risk in myelodysplastic syndrome

不匹配的修订版与分子国际预后评分系统风险在骨髓增生异常综合征中的影响

Leukemia
IF13.4
2025-09-050
PRE
Alexandre Bazinet; Guillermo Montalban-Bravo; Alex Bataller; Danielle Hammond; Sanam Loghavi; Kelly Chien; Koji Sasaki; Ian Bouligny; Mahesh Swaminathan; Wei Ying Jen; Uday Popat; Tapan Kadia; Courtney DiNardo; Elias Jabbour; Nicholas Short; Naval Daver; Farhad Ravandi; Guillermo Garcia-Manero
Outcomes and Patterns of Relapse of NPM1 Mutated Acute Myeloid Leukemia Treated With Venetoclax Based Therapies

NPM1突变急性髓系白血病经维奈克拉为基础的治疗后的结局与复发模式

American Journal of Hematology
IF9.9
2025-08-280
PREAI
Wei-Ying Jen; Sanam Loghavi; Alexandre Bazinet; Alex Bataller; Ian Bouligny; Naval G. Daver; Ghayas C. Issa; Naszrin Arani; Emmanuel Almanza Huante; Abhishek Maiti; Guillermo Montalban-Bravo; Gautam Borthakur; Nicholas J. Short; Sherry Pierce; Elias Jabbour; Guillermo Garcia-Manero; Farhad Ravandi; Hagop M. Kantarjian; Courtney D. DiNardo; Tapan M. Kadia
Outcomes of adult patients with newly diagnosed IDH-mutated AML treated with intensive chemotherapy and venetoclax

新诊断IDH突变型AML成人患者接受强化化疗和维奈克拉治疗后的结局

Leukemia
IF13.4
2025-08-140
PRE
Jennifer Croden; Wei-Ying Jen; Jennifer Marvin-Peek; Lianchun Xiao; Ian M. Bouligny; Sanam Loghavi; Gautam Borthakur; Naval G. Daver; Hussein A. Abbas; Koichi Takahashi; Koji Sasaki; Naveen Pemmaraju; Nicholas J. Short; Danielle Hammond; Elias Jabbour; Lucia Masarova; Kelly S. Chien; Ghayas C. Issa; Guillermo Montalban-Bravo; Musa Yilmaz; Abhishek Maiti; Yesid Alvarado-Valero; Guillermo Garcia-Manero; Farhad Ravandi; Marina Y. Konopleva; Hagop M. Kantarjian; Tapan M. Kadia; Courtney D. DiNardo
Contemporary outcomes of octa-nonagenarians with newly diagnosed acute myeloid leukemia

新诊断急性髓系白血病八旬以上患者当代预后

Cancer
IF5.1
2025-08-070
OAAI
Jayastu Senapati MD, DM; Hagop M. Kantarjian MD; Tapan M. Kadia MD; Jeannot Kekedjian MD; Gautam Borthakur MD; Naval Daver MD; Courtney D. DiNardo MD, MSCE; Elias Jabbour MD; Prithviraj Bose MD; Nicholas J. Short MD; Musa Yilmaz MD; Nitin Jain MD; Naveen Pemmaraju MD; Hussein A. Abbas MD, PhD; Ghayas C. Issa MD; Abhishek Maiti MD; Guillermo Montalban Bravo MD; Indraneel Deshmukh MBBS; Elizabeth Shpall MD; Partow Kebriaei MD; Uday Popat MD; Sanam Loghavi MD; Beenu Thakral MD; Guilin Tang MD; Fadi G. Haddad MD; Yesid Alvarado MD; Guillermo Garcia Manero MD; Farhad Ravandi MD
Erythroid-predominant myelodysplastic neoplasms exhibit a distinct genomic landscape with poor outcomes after venetoclax-based therapy

红系为主的骨髓增生异常肿瘤表现出独特的基因组景观，在维奈克拉为基础的治疗后预后较差。

Leukemia
IF13.4
2025-07-210
PRE
Alexandre Bazinet; Sanam Loghavi; Yue Wei; Alex Bataller; Koji Sasaki; Naszrin Arani; Faezeh Darbaniyan; Kelly Chien; Danielle Hammond; Ian Bouligny; Rashmi Kanagal-Shamanna; Natthakan Thongon; Guilin Tang; Samuel Urrutia; Tapan Kadia; Courtney DiNardo; Naval Daver; Nicholas Short; Ghayas Issa; Naveen Pemmaraju; Elias Jabbour; Sa A. Wang; Wei Wang; Gautam Borthakur; Carlos Bueso-Ramos; Farhad Ravandi; L. Jeffrey Medeiros; Hagop Kantarjian; Guillermo Garcia-Manero; Guillermo Montalban-Bravo
Landscape and clinicopathologic features of RAS pathway mutations in chronic myelomonocytic leukemia

RAS通路突变在慢性髓单核细胞白血病中的景观及临床病理特征

Blood Advances
IF7.1
2025-07-150
OAAI
Guillermo Montalban-Bravo; Sanam Loghavi; Ziyi Li; Kelly Chien; Rashmi Kanagal-Shamanna; Alex Bataller; Anuya Natu; Mark Gurney; Alexandre Bazinet; Danielle Hammond; Koji Sasaki; Gautam Borthakur; Mahesh Swaminathan; Courtney DiNardo; Tapan Kadia; Farhad Ravandi; Naval Daver; Nicholas Short; Naveen Pemmaraju; Ghayas Issa; Terra L. Lasho; Christy M. Finke; Aref Al-Kali; Clifford Csizmar; Hassan Alkhateeb; Naseema Gangat; Abhishek A. Mangaonkar; Carlos Bueso-Ramos; Ayalew Tefferi; Hagop Kantarjian; Guillermo Garcia-Manero; Mrinal M. Patnaik
Multiple TET2 mutations confer additional survival benefit in both myelodysplastic and myeloproliferative chronic myelomonocytic leukemia subtypes

多个TET2突变在骨髓增生异常和骨髓增生性慢性粒单核细胞白血病亚型中均带来额外的生存益处

Leukemia
IF13.4
2025-06-240
PRE
Clifford M. Csizmar; Anuya Natu; Mark Gurney; Saubia Fathima; Ali Khalid A. Alsugair; Rashmi Kanagal-Shamanna; Sanam Loghavi; Alexandre Bazinet; Kelly Chien; Danielle Hammond; Courtney DiNardo; Tapan Kadia; Farhad Ravandi-Kashani; Naveen Pemmaraju; Koji Sasaki; Terra L. Lasho; Christy M. Finke; Aref Al-Kali; Hassan Alkhateeb; Kebede Begna; Naseema Gangat; Mehrdad Hefazi Torghabeh; Aasiya Matin; Abhishek A. Mangaonkar; Antoine N. Saliba; Ayalew Tefferi; Guillermo Garcia-Manero; Hagop M. Kantarjian; Rami S. Komrokji; Zhuoer Xie; Najla A. Ali; David Sallman; Eric Padron; Guillermo Montalban-Bravo; Mrinal M. Patnaik
BLAST: a globally applicable and molecularly versatile survival model for chronic myelomonocytic leukemia

BLAST：一种适用于全球范围且分子上具有多样性的慢性髓系单核细胞白血病患者生存模型

Blood
IF23.1
2025-05-090
PRE
Ayalew Tefferi; Saubia Fathima; Maymona Abdelmagid; Ali Khalid A. Alsugair; Fnu Aperna; Mahsa Rezasoltani; Muhammad Yousuf; Anuya Natu; Clifford M. Csizmar; Mark Gurney; Terra L. Lasho; Christy M. Finke; Rashmi Kangal-Shamanna; Danielle Hammond; Kelly Chien; Alexandre Bazinet; Courtney D. DiNardo; Tapan M. Kadia; Abhishek A. Mangaonkar; Naval Daver; Animesh Pardanani; Gautam Borthakur; Cinthya Zepeda-Mendoza; Kaaren K. Reichard; Rong He; Sanam Loghavi; Francesco Passamonti; Farhad Ravandi; Koji Sasaki; Dirk R. Larson; Guillermo Garcia-Manero; Francesco Onida; Naseema Gangat; Guillermo Montalban-Bravo; Mrinal M. Patnaik

研究方向

暂未获取到该数据
G
Guillermo Garcia‐Manero
H 指数:149论文数:2,934被引数:8.9万
T
Tapan M. Kadia
H 指数:89论文数:1,752被引数:3.2万
H
Hagop M. Kantarjian
H 指数:230论文数:5,484被引数:26.4万
F
Farhad Ravandi
H 指数:126论文数:2,443被引数:6.8万
C
Courtney D. DiNardo
H 指数:94论文数:1,588被引数:4.7万
E
Elias Jabbour
H 指数:115论文数:2,327被引数:5.5万
K
Koji Sasaki
H 指数:61论文数:1,088被引数:1.4万
N
Naval Daver
H 指数:89论文数:1,412被引数:3.3万
N
Nicholas J. Short
H 指数:64论文数:1,057被引数:1.6万
R
Rashmi Kanagal‐Shamanna
H 指数:61论文数:627被引数:1.5万